Buy Butylone (bk-MBDB) – Comprehensive Harm Reduction Guide: Chemistry, Effects, Risks, Dosage, Pharmacology, and Legal Insights
Check our Products on Sale!
OTHER PSYCHEDELICS
OTHER PSYCHEDELICS
MUSHROOM INFUSED EDIBLES
Critical Disclaimer: This is created solely for educational and harm-reduction purposes. We do not promote, encourage, endorse, or provide any guidance on purchasing, possessing, using, distributing, or manufacturing Butylone (also known as bk-MBDB, β-keto-N-methylbenzodioxolylbutanamine, or B1), or any related synthetic cathinones. Butylone is classified as a Schedule I controlled substance in the United States (under 21 CFR § 1308.11, with temporary scheduling extensions confirmed through at least July 2026), indicating high abuse potential and no accepted medical use. It is similarly controlled in many countries: Class B in the UK, Anlage II in Germany (authorized trade only, not prescriptible), and illegal in Poland, Norway, Japan, Israel, Finland, and others. In some jurisdictions, it falls under broader analog acts or designer drug bans. As of March 2026, no changes have legalized recreational use; research remains tightly restricted. Possession or use carries severe legal risks, including criminal penalties. This content draws from scientific literature, harm-reduction resources, and community reports to inform those who might encounter this substance always prioritize safety, obey laws, and seek professional medical or mental health support if needed.
Butylone emerged in the mid-2000s as part of the “legal high” wave, often sold online as “bath salts,” “plant food,” or “research chemicals” with disclaimers like “not for human consumption.” It belongs to the synthetic cathinones family beta-keto analogs of amphetamines and shares structural similarities with MDMA (ecstasy) and methylone. While less prevalent today due to bans, it persists in niche discussions for its entactogenic and stimulant properties.
Chemical Structure and Nomenclature
Check our bestsellers!
MUSHROOM INFUSED EDIBLES
MUSHROOM INFUSED EDIBLES
MUSHROOM INFUSED EDIBLES
OTHER PSYCHEDELICS
MUSHROOM CAPSULES
MUSHROOM INFUSED EDIBLES
DRIED MUSHROOMS
DRIED MUSHROOMS
OTHER PSYCHEDELICS
MUSHROOM INFUSED EDIBLES
Butylone’s systematic name is 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one. It features a methylenedioxy ring (like MDMA), a beta-keto group, and an N-methyl substitution, making it the β-keto analog of MBDB (N-methyl-1,3-benzodioxolylbutanamine). The “butyl” refers to the ethyl side chain at the alpha position, distinguishing it from methylone (which has a methyl side chain).
Common synonyms include:
- bk-MBDB
- βk-MBDB
- B1
- β-keto-N-methylbenzodioxolylbutanamine
Note: “Butylone” can cause confusion with the barbiturate pentobarbital (formerly trademarked as Butylone). The term is a misnomer; the precise class name would be phenyl-sec-butylamine derivatives.
Molecular formula: C₁₂H₁₅NO₃ Molecular weight: 221.25 g/mol CAS Number: 17762-90-2 (freebase); hydrochloride salt common in samples.
For detailed chemical data, refer to PubChem’s Butylone entry, which includes structure, synonyms, and safety info.
Pharmacology and Mechanism of Action
Butylone acts as a monoamine releaser and reuptake inhibitor, primarily affecting serotonin (5-HT), dopamine (DA), and norepinephrine (NE). It increases extracellular levels of these neurotransmitters, similar to MDMA and methylone, but with a profile leaning toward entactogenic (empathy-enhancing) and mild stimulant effects rather than pure euphoria or intense stimulation.
Key mechanisms:
- Serotonin release — Strong, contributing to empathogenic feelings (openness, emotional warmth).
- Dopamine and norepinephrine release/inhibition — Moderate, leading to energy, alertness, and mild euphoria.
- Hybrid activity — Acts as a non-selective monoamine uptake blocker (like cocaine) while promoting release (like amphetamines/MDMA).
Studies show butylone induces hyperlocomotion in rats via 5-HT2A receptor activation and dopamine increases, preventable by antagonists like ketanserin or haloperidol. It substitutes partially for stimulants in animal models but is less potent than mephedrone or MDPV.
Compared to related compounds:
- Methylone (bk-MDMA): Similar but shorter duration.
- Ethylone (bk-MDEA): More serotonergic.
- MDPV: Pure reuptake inhibitor, more compulsive/stimulating.
Duration: 2–5 hours (oral/nasal), shorter than MDMA.
For in-depth pharmacology, see the Wikipedia page on Butylone, which summarizes binding affinities and effects, or PsychonautWiki’s detailed Butylone entry, including subjective comparisons.
Effects: What Users Report
Butylone produces a blend of stimulant and entactogenic effects, often described as milder than MDMA:
- Positive — Euphoria, increased empathy/openness, energy/alertness, enhanced music appreciation, mild visuals at higher doses, libido increase.
- Neutral — Jaw clenching, pupil dilation, dehydration, time distortion.
- Negative — Anxiety, paranoia (especially high doses), insomnia, vasoconstriction, nausea, post-use crash (depression/fatigue).
Subjective reports (from harm-reduction sites like Erowid) note it’s “subtler” than methylone less “loved-up” but with decent mood lift and stimulation. Nasal use causes irritation; oral is preferred.
Dose ranges (anecdotal, not medical advice):
- Threshold: 50–100 mg
- Common: 100–200 mg
- Strong: 200+ mg (higher risk of adverse effects)
Redosing common due to short duration, but increases neurotoxicity risk.
Explore user experiences on Erowid’s bk-MBDB Vault, which includes reports and dosage info.
Risks and Adverse Effects
Butylone carries significant harms, especially at high/repeated doses:
- Cardiovascular — Tachycardia, hypertension, chest pain, arrhythmias.
- Neurological — Agitation, confusion, seizures, hyperthermia.
- Psychiatric — Anxiety, paranoia, psychosis, depression during comedown.
- Other — Rhabdomyolysis, hyponatremia (from overhydration), vasoconstriction, serotonin syndrome (with MAOIs/SSRIs).
Fatalities linked to butylone involve polydrug use, falls, or organ failure. Overdose risk high due to variable purity in “bath salts.”
Harm reduction tips:
- Test substances (reagents for cathinones).
- Start low, avoid mixing (especially with stimulants/serotonergics).
- Hydrate moderately, monitor temperature.
- Have support during use.
For risks overview, see the PMC article on Synthetic Cathinones Harms, detailing toxicology.
Legal Status in 2026
Butylone is Schedule I in the US (extended through 2026 via DEA temporary orders). Controlled internationally under analog acts or specific bans. No therapeutic use; research limited.
Comparison to Related Substances and Niche Insights
Butylone is part of the beta-keto cathinone family (e.g., methylone, ethylone). Blogs/forums discuss it as a “milder MDMA alternative,” but with higher neurotoxicity potential from repeated use.
For natural psychedelic parallels (e.g., psilocybin for mental health), see IMA Fungi’s Golden Teacher Mushrooms guide or Albino Penis Envy overview.
Final Note: This is informational only. Synthetic cathinones like butylone pose serious risks avoid if possible. Seek help for substance concerns.
Related products
OTHER PSYCHEDELICS
OTHER PSYCHEDELICS
OTHER PSYCHEDELICS
OTHER PSYCHEDELICS
OTHER PSYCHEDELICS
OTHER PSYCHEDELICS
OTHER PSYCHEDELICS